DUSP9 and colorectal cancer: The high methylation status of CpG islands in the DUSP9 promoter may lead to the downregulation of DUSP9 in (colorectal cancer, CRC), while upregulation of DUSP9 can inhibit the proliferation, migration, invasion, and epithelial-mesenchymal transition of CRC cells (30).